Cheryl L. Limebeer

Suggest Changes

Writes About:

Learn More
A growing body of evidence suggests that cannabinoid CB1 receptor antagonists have potential therapeutic utility as appetite suppressants. However, the specific mechanisms underlying the reduction in(More)